{
  "id": 4183116,
  "title": "Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial",
  "url": "https://urgent.news/2026/08/29/dual-antithrombotic-therapy-using-potent-antiplatelet-inhibitors-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-29T00:00:00.000Z",
  "source": {
    "name": "Nature Medicine",
    "slug": "nature-medicine",
    "url": "https://www.nature.com/articles/s41591-026-04629-7"
  },
  "original_language": "en",
  "account": null,
  "summary": "Nature Medicine, Published online: 29 August 2026; doi:10.1038/s41591-026-04629-7 As presented at the 2026 European Society of Cardiology Congress, use of direct oral anticoagulants together with potent P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome was associated with higher bleeding rates without evidence of reduced ischemic events, as compared to direct oral…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}